Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
EuroIntervention ; 10(3): 329-36, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25042265

ABSTRACT

AIMS: Patients with symptomatic chronic total occlusions (CTO) remain a therapeutic challenge. Enhancement of intraluminal neovascularisation by pro-angiogenic therapies has been proposed as a new strategy to improve percutaneous revascularisation. The aim of this study was to investigate the effects of intraluminal injection of bone marrow-derived cells (BMC) into experimental CTO. METHODS AND RESULTS: CTO were created in the femoral arteries of 43 New Zealand White rabbits using the thrombin injection model. At 12 weeks following CTO creation, 33 rabbits were injected with either cultured BMC (n=19) or control DMEM alone (n=14) directly into the CTO. Ten rabbits were used for cell tracking (seven BMC and three control). BMC labelled with fluorescent Qdot® nanocrystals were identified in the CTO up to one week after injection. Animals were sacrificed at three to five weeks post-treatment and arterial samples were excised for micro-CT imaging and histologic morphometric analysis. There was a significant but modest increase in neovascularisation in BMC-treated arteries compared to controls (7.47±4.75% vs. 4.35±2.97%, p<0.05). However, unexpected intravascular calcification was only detected within the CTO in BMC cell treated arteries. Western blot for conditioned medium from BMC showed up-regulation of osteogenic proteins (BMP-2 and -7). CONCLUSIONS: Although direct delivery of BMC into CTO increases neovascularisation, undesirable vascular calcification will limit this therapeutic approach.


Subject(s)
Arterial Occlusive Diseases/surgery , Bone Marrow Cells , Bone Marrow Transplantation/adverse effects , Femoral Artery/pathology , Vascular Calcification/etiology , Angiogenic Proteins/metabolism , Animals , Arterial Occlusive Diseases/chemically induced , Arterial Occlusive Diseases/metabolism , Arterial Occlusive Diseases/pathology , Arterial Occlusive Diseases/physiopathology , Biomarkers/metabolism , Bone Marrow Cells/metabolism , Bone Morphogenetic Protein 2/metabolism , Bone Morphogenetic Protein 7/metabolism , Cell Tracking , Cells, Cultured , Chronic Disease , Disease Models, Animal , Femoral Artery/diagnostic imaging , Femoral Artery/metabolism , Femoral Artery/physiopathology , Neovascularization, Physiologic , Osteogenesis , Rabbits , Thrombin , Time Factors , Transplantation, Autologous , Vascular Calcification/metabolism , Vascular Calcification/pathology , X-Ray Microtomography
2.
J Am Coll Cardiol ; 53(13): 1148-58, 2009 Mar 31.
Article in English | MEDLINE | ID: mdl-19324261

ABSTRACT

OBJECTIVES: We sought to perform the first systematic study of the natural history of chronic total arterial occlusions (CTOs) in an experimental model. BACKGROUND: Angioplasty of CTOs has low success rates. The structural and perfusion changes during CTO maturation, which may adversely affect angioplasty outcome, have not been systematically studied. METHODS: Occlusions were created in 63 rabbit femoral arteries by thrombin injection. Histology, contrast-enhanced magnetic resonance imaging, relative blood volume (RBV) index, and micro-computed tomography imaging were analyzed at 2, 6, 12, and 18 to 24 weeks. RESULTS: Early changes were characterized by an acute inflammatory response and negative arterial remodeling, with >70% reduction of arterial cross-sectional area (CSA) from 2 to 6 weeks. Intraluminal neovascularization of the CTO occurred with a 2-fold increase in total (media + intima) microvessel CSA from 2 to 6 weeks (0.014 +/- 0.002 mm2 to 0.023 +/- 0.005 mm2, p = 0.0008) and a 3-fold increase in RBV index (5.1 +/- 1.9% to 16.9 +/- 2.7%, p = 0.0008). However at later time periods, there were significant reductions in both RBV (3.5 +/- 1.1%, p < 0.0001) and total microvessel CSA (0.017 +/- 0.002 mm2, p = 0.011). Micro-computed tomography imaging demonstrated a corkscrew-like recanalization channel at the proximal end at 6 weeks that regressed at later time points. These vascular changes were accompanied by a marked decrease in proteoglycans and accumulation of a collagen-enriched extracellular matrix, particularly at the entrance ("proximal fibrous cap"). CONCLUSIONS: This study is the first to systematically analyze compositional changes occurring during CTO maturation, which may underlie angioplasty failure. Negative remodeling, regression of intraluminal channels, and CTO perfusion, together with the accumulation of dense collagen, may represent important targets for novel therapeutic interventions.


Subject(s)
Thrombosis/physiopathology , Angioplasty , Animals , Blood Volume , Chronic Disease , Disease Models, Animal , Extracellular Matrix/pathology , Femoral Artery , Magnetic Resonance Imaging , Male , Neovascularization, Pathologic , Rabbits , Thrombosis/pathology , Tomography, X-Ray Computed/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...